W. Al Arashi

Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling

A. Janssen, M. Kruip, R. Mathôt, 2022, CPT: pharmacometrics & systems pharmacology.

Patient‐reported outcomes in autosomal inherited bleeding disorders: A systematic literature review

Hester F. Lingsma, J. Hazelzet, M. Cnossen, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling

M. Hoogendoorn, A. Janssen, F. Leebeek, 2022, CPT: pharmacometrics & systems pharmacology.

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study

C. Zwaan, R. Mathôt, M. Cnossen, 2022, BMJ Open.

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort

E. Hensor, H. Marzo-Ortega, I. E. van der Horst-Bruinsma, 2018, Rheumatology advances in practice.

Desmopressin testing in von Willebrand disease: Lowering the burden

M. Kruip, M. Cnossen, F. Leebeek, 2022, Research and practice in thrombosis and haemostasis.